Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A

NCT00717626 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: Kogenate FS, Advate, or Humate-P, Recombinate, Helixate FS

Sponsor

The Hospital for Sick Children